BioCentury
ARTICLE | Clinical News

Chronocort: Phase III started

October 24, 2016 7:00 AM UTC

Diurnal began an open-label, European Phase III trial to compare 5, 10 and 20 mg oral Chronocort vs. glucocorticoid replacement therapy in 110 patients....